2-Day Seminar on Nasal Drug Delivery (London, United Kingdom - April 11-12, 2019) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 22, 2019--The “Nasal Drug Delivery” conference has been added to ResearchAndMarkets.com’s offering.
This conference gives a comprehensive review within the field of nasal drug delivery while reviewing interesting new data and innovative technologies
What makes nasal delivery systems more challenging than solid dosage forms? How safe is nasal drug delivery? Are there such things as safe excipients? How does all this fit within the regulatory environment in Europe and the USA? How difficult is it to bring all these products to market?
This seminar seeks to explore these and other questions within the field of nasal drug delivery while reviewing interesting new data, innovative technologies and the very latest scientific developments. Leading authorities in nasal drug delivery will cover relevant aspects of nasal physiology, anatomy, absorption of a variety of drugs in various phases of drug development, and new drugs entering the market. In addition, nasal delivery to the sinuses will be discussed and the programme will include interesting case histories.
The seminar will offer an excellent networking opportunity to build business relationships and discuss all these issues with an unrivalled panel of experts in this field of drug delivery.
Three reasons to attend:
1. Gain an update on the very latest scientific developments and technology advances in this field
2. Hear from an unrivalled panel of expert speakers
3. An excellent networking opportunity to build business relationships
Who Should Attend?
Those already involved in nasal drug delivery will benefit from updating their knowledge and sharing experiences with some of the leading practitioners in this field. If you are involved in nasal drug delivery or are just considering the potential, this seminar is an excellent route to understanding all aspects from the basic physiology through to launching a successful product.
Nasal drugs to treat nasal disorders: a comprehensive review
Nasal drug delivery challenges
Nasal formulation of drugs
Developing next generation powder nasal delivery using POD technology
Rethinking nasal packaging environment
Key insights for a successful device development to achieve nasal bioequivalence requirements
The unique challenges of nasal drug delivery to treat chronic rhinosinusitis (CRS); considerations before and after sinus surgery
Review of nasal drug delivery devices
Requirements concerning bioequivalence of nasal drug products from an authority’s point of view
Regulatory science associated with BE/TE for nasal products
US/FDA regulatory guidance on combination products
Qualification of new nasal drug delivery systems for existing drugs
Investigations regarding the developability of nasal metered dose inhalers
What are chemisimilars and what’s the problem?
Close of conference and refreshments
For more information about this conference visit https://www.researchandmarkets.com/research/k79ns8/2day_seminar_on?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190222005337/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Transdermal and Transmucosal Drug Delivery
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/22/2019 10:43 AM/DISC: 02/22/2019 10:43 AM